| Duration of menopausal vasomotor symptoms over the menopause transition NE Avis, SL Crawford, G Greendale, JT Bromberger, SA Everson-Rose, ... JAMA internal medicine 175 (4), 531-539, 2015 | 944 | 2015 |
| Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial C de Novaes Soares, OP Almeida, H Joffe, LS Cohen Archives of general psychiatry 58 (6), 529-534, 2001 | 930 | 2001 |
| Sociodemographic predictors of antenatal and postpartum depressive symptoms among women in a medical group practice JW Rich-Edwards, K Kleinman, A Abrams, BL Harlow, TJ McLaughlin, ... Journal of Epidemiology & Community Health 60 (3), 221-227, 2006 | 877 | 2006 |
| Vasomotor symptoms and menopause: findings from the Study of Women's Health across the Nation RC Thurston, H Joffe Obstetrics and Gynecology Clinics 38 (3), 489-501, 2011 | 444 | 2011 |
| Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge? H Joffe, LS Cohen Biological psychiatry 44 (9), 798-811, 1998 | 414 | 1998 |
| Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial EW Freeman, KA Guthrie, B Caan, B Sternfeld, LS Cohen, H Joffe, ... Jama 305 (3), 267-274, 2011 | 298 | 2011 |
| Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in … H Joffe, JE Hall, S Gruber, IA Sarmiento, LS Cohen, D Yurgelun-Todd, ... Menopause 13 (3), 411-422, 2006 | 281 | 2006 |
| Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care H Joffe, JE Hall, CN Soares, J Hennen, CJ Reilly, K Carlson, LS Cohen Menopause 9 (6), 392-398, 2002 | 279 | 2002 |
| Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model JL Gordon, SS Girdler, SE Meltzer-Brody, CS Stika, RC Thurston, ... American Journal of Psychiatry 172 (3), 227-236, 2015 | 256 | 2015 |
| Incidence of hospitalization for postpartum psychotic and bipolar episodes in women with and without prior prepregnancy or prenatal psychiatric hospitalizations BL Harlow, AF Vitonis, P Sparen, S Cnattingius, H Joffe, CM Hultman Archives of General Psychiatry 64 (1), 42-48, 2007 | 251 | 2007 |
| Sleep during the perimenopause: a SWAN story HM Kravitz, H Joffe Obstetrics and Gynecology Clinics 38 (3), 567-586, 2011 | 250 | 2011 |
| Impact of oral contraceptive pill use on premenstrual mood: predictors of improvement and deterioration H Joffe, LS Cohen, BL Harlow American journal of obstetrics and gynecology 189 (6), 1523-1530, 2003 | 240 | 2003 |
| Evaluation and management of sleep disturbance during the menopause transition H Joffe, A Massler, KM Sharkey Seminars in reproductive medicine 28 (05), 404-421, 2010 | 230 | 2010 |
| Efficacy of exercise for menopausal symptoms: a randomized controlled trial B Sternfeld, KA Guthrie, KE Ensrud, AZ LaCroix, JC Larson, AL Dunn, ... Menopause 21 (4), 330-338, 2014 | 220 | 2014 |
| Sex and gender differences in health: what the COVID-19 pandemic can teach us PA Spagnolo, JAE Manson, H Joffe Annals of Internal Medicine 173 (5), 385-386, 2020 | 215 | 2020 |
| Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations PM Maki, SG Kornstein, H Joffe, JT Bromberger, EW Freeman, ... Journal of women's health 28 (2), 117-134, 2019 | 208* | 2019 |
| Beyond frequency: who is most bothered by vasomotor symptoms? RC Thurston, JT Bromberger, H Joffe, NE Avis, R Hess, CJ Crandall, ... Menopause 15 (5), 841-847, 2008 | 206 | 2008 |
| Gender differences in bipolar disorder: retrospective data from the first 500 STEP‐BD participants CF Baldassano, LB Marangell, L Gyulai, S Nassir Ghaemi, H Joffe, ... Bipolar disorders 7 (5), 465-470, 2005 | 205 | 2005 |
| Menopause-associated symptoms and cognitive performance: results from the study of women's health across the nation GA Greendale, RG Wight, MH Huang, N Avis, EB Gold, H Joffe, T Seeman, ... American journal of epidemiology 171 (11), 1214-1224, 2010 | 198 | 2010 |
| Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial H Joffe, KA Guthrie, AZ LaCroix, SD Reed, KE Ensrud, JAE Manson, ... JAMA internal medicine 174 (7), 1058-1066, 2014 | 192 | 2014 |
